CEL-SCI Co. (NYSEAMERICAN:CVM) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 643,794 shares, a drop of 15.3% from the January 12th total of 759,737 shares. Approximately 5.9% of the shares of the company are sold short. Based on an average daily trading volume, of 272,421 shares, the short-interest ratio is currently 2.4 days.

CEL-SCI (NYSEAMERICAN CVM) opened at $1.75 on Wednesday. CEL-SCI has a 1 year low of $1.46 and a 1 year high of $4.00. The firm has a market cap of $21.77, a price-to-earnings ratio of -1.09 and a beta of -1.49.

CEL-SCI (NYSEAMERICAN:CVM) last posted its quarterly earnings data on Monday, February 12th. The company reported ($0.53) earnings per share for the quarter. The company had revenue of $0.11 million for the quarter.

TRADEMARK VIOLATION NOTICE: “CEL-SCI Co. (CVM) Short Interest Update” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/02/14/cel-sci-co-cvm-short-interest-update.html.

About CEL-SCI

CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.

Receive News & Ratings for CEL-SCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI and related companies with MarketBeat.com's FREE daily email newsletter.